Medstar Health Research Institute
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Medstar Health Research Institute sits in the top decile of US sponsors by registered trial count (#223 of 15,742 sponsors by registered trial count).
Medstar Health Research Institute: 115 sponsored US clinical trials, 23 recruiting.
Medstar Health Research Institute sponsors 115 registered US clinical trials on ClinicalTrials.gov, 23 of them currently recruiting, and 65 completed. 16 of these trials are in Phase 3-4 (later-stage) and 18 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Neurogenic Bladder, with 5 trials.
Top-decile sponsor footprint
Medstar Health Research Institute ranks in the top decile of sponsors by registered trial count (#223 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
65 of 83 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (78.3%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
115 total, page 1 of 3
Comparing Collared and Collarless Femoral Stems in Primary Total Hip Arthroplasty
NCT07337642
Digital Intervention for Symptom Management in Cancer and Opioid Sparing Using Virtual Reality (DISCOVR) Study
NCT07228377
Diagnostic Journey, Patient Experience, and Disparities in the Treatment of Spinal Muscular Atrophy (SMA) in the MedStar Health System
NCT07223489
Intravesical Lactobacillus Crispatus: Clinical Safety and Microbiome Evaluation
NCT07308808
Rimegepant as Preemptive Treatment for Predictable Trigger-Induced Migraine in Adult Patients in the US
NCT07301008
Cognitive Behavioral Theory-assisted Virtual Reality for Chronic CANcer Pain (VR-CAN)
NCT07318519
Patient and Caregiver Perspectives on Intravesical Instillations for Urinary Symptoms
NCT07390591
Assessment of Tubal Occlusion During Minimally Invasive Myomectomy
NCT06988774
APPROVE Trial: Evaluating a Prescription Digital Therapeutic for Treatment of OAB in Women
NCT06797245
VIBRating vs Traditional Therapy for Treatment of ENTry Dyspareunia
NCT06840314
Paraffin Wax and Exercise Prospective
NCT06786884
NPWT Reduction Mammaplasty
NCT06725459
POMEGRANATE Trial: Comparing Reia Pessary Versus Standard of Care Pessary for Pelvic Organ Prolapse Treatment
NCT06634459
REmote Symptom COllection to improVE postopeRative Care
NCT06190730
Optimal Pacing Rate for Cardiac Resynchronization Therapy
NCT06445439
Treatment of Hypopigmented Scars With Bimatoprost
NCT06122090
Coronary Microvascular Disease (CMD) Registry
NCT05960474
Intravesical LGG VS Saline Bladder Wash RCT
NCT05230511
Hand Exoskeleton Training Study
NCT06786858
Regenerative Peripheral Nerve Interfaces to Treat Painful Digit and Hand Neuromas After Amputation
NCT05008185
Mitral Valve Screening Survey
NCT04736667
Intravesical Lactobacillus for Urinary Symptoms Among People With NLUTD Who Use Indwelling Catheters
NCT04323735
Transcatheter Aortic Prosthesis Function: A Long-term Follow-up Study
NCT03002272
PRP Injections for Genitourinary Syndrome of Menopause
NCT06028009
Stroke Research Initiative to Advance Equity
NCT06075719
Qualitative Assessment of the Impact of TTNS on QOL and Participation
NCT04248322
Social Risk Factors and Discrimination in Cancer Survivorship
NCT05301114
Pharmacogenomics Applied to Chronic Pain Treatment in Primary Care
NCT04685304
IMPact on Revascularization Outcomes of IVUS Guided Treatment of Complex Lesions and Economic Impact
NCT04221815
CO2 Laser Revision for Burn Related Donor Site Scars
NCT04456127
Coupled Gentamicin-Lactobacillus Rhamnosus in NLUTD
NCT07643974
Palliative Care Intervention to Improve Health Related Quality of Life for Patients on Long-Term LVAD Support
NCT07445932
Local Anesthesia Before Bulkamid Injection
NCT06043063
Vaginal Injection of Platelet Rich Plasma for Sexual Function
NCT05769283
Reshaping Postpartum Follow-up
NCT06054841
Transvaginal Low-level Laser Therapy to Improve Pelvic Pain and Sexual Function in Patients with Endometriosis.
NCT05540353
Socio-Structural Intervention to Improve Pre-Exposure Prophylaxis Services for Cisgender Women
NCT07318532
Art Therapy in Obstetric Patients
NCT05503056
Device Feasibility and Acceptability to Improve Insomnia in Cancer
NCT05875129
Virtual Reality for Outpatient Cancer Pain Management
NCT05442866
mHealth for Breast Cancer Survivors With Insomnia
NCT05233800
Fractionated CO2 Laser With and Without Clobetasol for Treatment of Vulvar Lichen Sclerosus
NCT04951206
Massage Therapy for Self-efficacy in LVAD Recipients
NCT04018508
Comorbidities And Reducing inEquitieS
NCT04836221
Assessment of Postpartum Education to Improve Compliance
NCT04486170
Intravesical Lactobacillus to Reduce Urinary Symptoms After Spinal Cord Injury
NCT04373512
Virtual Reality Effects on Pain During Hysteroscopy Hysteroscopy: A Randomized Control Trial
NCT04802460
Virtual Reality for Cancer Pain Management
NCT04572074
Educational Video on Pain Management and Subsequent Opioid Use After Cesarean Delivery
NCT03959969
Efficacy of Paxman Scalp Cooling to Prevent Chemo Induced Alopecia in Black Patients With Breast or GYN Cancers
NCT04626895
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 3 |
| Phase 2 | 15 |
| Phase 3 | 4 |
| Phase 4 | 12 |
Therapeutic Areas
What is open in the Medstar Health Research Institute pipeline
23 recruiting of 115 indexed (20% open); 65 completed (57%).
Phase mix: 16 late (III/IV) vs 18 early (I/II) (balanced across stages).
Top condition: Neurogenic Bladder (5 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Medstar Health Research Institute: open-pipeline peers nationwide
Peers matched on 115 registered trials and 20% open enrollment, not the therapeutic-area sidebar.
Medstar Health Research Institute sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 115 trials (± recruiting share)
- Medtronic Cardiac Rhythm and Heart Failure · 115 trials · 2% recruiting
- Zimmer Biomet · 115 trials · 10% recruiting
- Rockefeller University · 117 trials · 4% recruiting
- State University of New York - Upstate Medical University · 113 trials · 7% recruiting
Sponsors near 20% open enrollment (± trial volume)
- Acera Surgical · 20% recruiting · 5 trials
- Align Technology · 20% recruiting · 5 trials
- AltruBio · 20% recruiting · 5 trials
- Alvernia University · 20% recruiting · 5 trials
Related
What to do with this Medstar Health Research Institute page
115 registered trials is a research-attention snapshot, not an endorsement of Medstar Health Research Institute or any single study.
- 23 of Medstar Health Research Institute's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Neurogenic Bladder is the condition Medstar Health Research Institute studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Neurogenic Bladder trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Medstar Health Research Institute pipeline card: 115 registered trials from official public datasets.Report a data error.